Polynovo
PolyNovo specializes in developing and commercializing advanced medical devices using its proprietary NovoSorb technology. The company focuses on treating burns, surgical wounds, and providing solutions for Negative Pressure Wound Therapy, positioning itself as a leader in innovative healthcare solutions.
Short position
Polynovo (ASX:PNV) has 7.06% of its shares on issue reported as short positions as of 5 Oct 2026, or about 48,746,700 shares. Over the past 30 days that figure has fallen 0.90 percentage points, and over 90 days it has fallen 1.54 percentage points. Its highest recorded short interest was 14.61% in May 2026. PNV is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Polynovo (PNV) short interest history
PNV Short Interest History
- 30-day change
- -0.90pp
- 90-day change
- -1.54pp
- 1-year change
- -2.83pp
- All-time high
- 14.61% (May 2026)
- All-time low
- 0.00% (September 2017)
Is PNV heavily shorted?
PNV's short interest of 7.06% is elevated relative to the ASX average, ranking #39 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has PNV's short interest changed recently?
Over the past 30 days Polynovo's short interest has fallen 0.90 percentage points, and over 90 days it has fallen 1.54 percentage points. The current level is 7.06% of shares on issue.
What is the highest PNV's short interest has been?
Since 2017, Polynovo's short interest peaked at 14.61% in May 2026 and bottomed at 0.00% in September 2017.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2017. See our methodology.